{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T19:58:03Z","timestamp":1720641483303},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.spen.2017.12.002","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T18:50:22Z","timestamp":1513795822000},"page":"123-135","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Psychiatric Treatment and Management of Psychiatric Comorbidities of Movement Disorders"],"prefix":"10.1016","volume":"25","author":[{"given":"Kelda Harris","family":"Walsh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Soe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivali","family":"Sarawgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2017.12.002_bib1","doi-asserted-by":"crossref","first-page":"1\/24","DOI":"10.1007\/s00787-007-1004-6","article-title":"Developmental psychopathology of children and adolescents with Tourette syndrome\u2014impact of ADHD","volume":"16","author":"Roessner","year":"2007","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib2","doi-asserted-by":"crossref","first-page":"1\/15","DOI":"10.1007\/s00787-007-1003-7","article-title":"Tourette Syndrome International Database Consortium: Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome","volume":"16","author":"Freeman","year":"2007","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib3","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1111\/j.1651-2227.2005.tb01837.x","article-title":"Tourette syndrome and other tic disorders in a total population of children: clinical assessment and background","volume":"94","author":"Khalifa","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.spen.2017.12.002_bib4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/WNL.59.3.414","article-title":"The behavioral spectrum of tic disorders: a community-based study","volume":"59","author":"Kurlan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.12.002_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00004583-200106000-00014","article-title":"Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit\/hyperactivity disorders in an epidemiological sample","volume":"40","author":"Peterson","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jaac.2013.09.015","article-title":"Practice parameter for the assessment and treatment of children and adolescents with tic disorders","volume":"52","author":"Murphy","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00787-011-0167-3","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioral and psychosocial interventions","volume":"20","author":"Verdellen","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib8","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/0145445505279379","article-title":"Controlled evaluation of an educational intervention used to modify peer attitudes and behavior toward persons with Tourette\u2019s syndrome","volume":"29","author":"Woods","year":"2005","journal-title":"Behav Modif"},{"key":"10.1016\/j.spen.2017.12.002_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jpepsy\/21.3.307","article-title":"Children\u2019s attitudes and behavioral intentions toward a peer with Tourette syndrome","volume":"21","author":"Friedrich","year":"1996","journal-title":"J Ped Psychol"},{"key":"10.1016\/j.spen.2017.12.002_bib10","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s00787-012-0362-x","article-title":"Tic disorders and Tourette\u2019s syndrome","volume":"22","author":"Plessen","year":"2013","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejpn.2013.01.005","article-title":"Tourette syndrome and comorbid ADHD: Current pharmacological treatment options","volume":"17","author":"Rizzo","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/cap.2012.0093","article-title":"A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit\/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability","volume":"23","author":"Treuer","year":"2013","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.spen.2017.12.002_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","article-title":"Clonidine treatment of Gilles de la Tourette\u2019s syndrome","volume":"48","author":"Leckman","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","article-title":"Treatment of ADHD in children with tics: a randomized controlled trial","volume":"58","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.12.002_bib15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/mds.20738","article-title":"Syncope in children with Tourette\u2019s syndrome treated with guanfacine","volume":"21","author":"King","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2017.12.002_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00032","article-title":"The efficacy and tolerability of the clonidine transdermal patch in the treatment for children with\u00a0tic disorders: a prospective, open, single-group, self-controlled study","volume":"8","author":"Song","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/CHI.0b013e3181b26e9f","article-title":"Meta-analysis: treatment of attention-deficit\/hyperactivity disorder in children with comorbid tic disorders","volume":"48","author":"Bloch","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1017\/S0012162206001290","article-title":"First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants","volume":"48","author":"Roessner","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaac.2015.06.011","article-title":"Meta-analysis: risk of tics associated with psychostimulant use in randomized, placebo-controlled trials","volume":"54","author":"Cohen","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/chi.0b013e31805c0860","article-title":"Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder","volume":"46","author":"Gadow","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00004583-199705000-00008","article-title":"Controlled stimulant treatment of ADHD and comorbid Tourette\u2032s syndrome: effects of stimulant and dose","volume":"36","author":"Castellanos","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib23","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1212\/01.wnl.0000188869.58300.a7","article-title":"Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders","volume":"65","author":"Allen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.12.002_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1087054707306109","article-title":"Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome","volume":"11","author":"Spencer","year":"2008","journal-title":"J Att Dis"},{"key":"10.1016\/j.spen.2017.12.002_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/NDT.S115707","article-title":"A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities","volume":"13","author":"Clemow","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.spen.2017.12.002_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00787-006-0505-z","article-title":"Attention deficit hyperactivity disorder, tics and Tourette\u2019s syndrome: the relationship and treatment implications. A commentary","volume":"15","author":"Robertson","year":"2006","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib27","series-title":"Diagnostic and statistical manual of mental disorders","first-page":"237","article-title":"Obsessive-compulsive disorder","year":"2013"},{"key":"10.1016\/j.spen.2017.12.002_bib28","doi-asserted-by":"crossref","first-page":"e12959","DOI":"10.1371\/journal.pone.0012959","article-title":"Repetitive behavior in patients with Gilles de la Tourette syndrome: tics, compulsions, or both?","volume":"5","author":"Worbe","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.spen.2017.12.002_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.36.3.378","article-title":"Obsessions and compulsions in Gilles de la Tourette\u2032s syndrome","volume":"36","author":"Frankel","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.12.002_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1176\/ajp.150.1.93","article-title":"Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette\u2032s syndrome","volume":"150","author":"George","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib31","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination with children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial","volume":"292","author":"Pediatric","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.spen.2017.12.002_bib32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children\u2019s Yale-Brown Obsessive-Compulsive Scale: reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.chi.0000172555.26349.94","article-title":"Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: long-term follow-up and predictors of outcome","volume":"44","author":"Barrett","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00004583-199804000-00019","article-title":"Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial","volume":"37","author":"Franklin","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00004583-199403000-00006","article-title":"Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package","volume":"33","author":"March","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib36","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.2011.1344","article-title":"Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial","volume":"306","author":"Franklin","year":"2011","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.spen.2017.12.002_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpsychires.2017.04.001","article-title":"Secondary outcomes from the pediatric obsessive compulsive disorder treatment study II","volume":"92","author":"Conelea","year":"2017","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.spen.2017.12.002_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1753-2000-3-4","article-title":"The Pediatric Obsessive-Compulsive Disorder Treatment Study II: rationale, design and methods","volume":"3","author":"Freeman","year":"2009","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"10.1016\/j.spen.2017.12.002_bib39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biopsych.2006.09.035","article-title":"Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder","volume":"61","author":"March","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib40","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaac.2011.09.019","article-title":"Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder","volume":"51","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0005-7894(05)80054-1","article-title":"The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis","volume":"36","author":"Abramowitz","year":"2005","journal-title":"Behav Ther"},{"key":"10.1016\/j.spen.2017.12.002_bib42","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1097\/00004583-199810001-00003","article-title":"Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder","volume":"37","author":"King","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.psc.2014.05.002","article-title":"Cognitive behavior therapy for obsessive-compulsive and related disorders","volume":"37","author":"Lewin","year":"2014","journal-title":"Psychiatr Clin N Am"},{"key":"10.1016\/j.spen.2017.12.002_bib44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.1992.01820090009002","article-title":"Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder","volume":"49","author":"Baxter","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib45","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jpsychires.2012.11.010","article-title":"Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder","volume":"47","author":"O\u2019Neill","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.spen.2017.12.002_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.brat.2007.10.003","article-title":"Optimizing inhibitory learning during exposure therapy","volume":"46","author":"Craske","year":"2008","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.spen.2017.12.002_bib47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/chi.0b013e31803062e7","article-title":"Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches","volume":"46","author":"Storch","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib48","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00004583-200401000-00014","article-title":"Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial","volume":"43","author":"Barrett","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.janxdis.2017.03.010","article-title":"Cognitive-behavioral high parental involvement treatments for pediatric obsessive-compulsive disorder: a meta-analysis","volume":"49","author":"Iniesta-Sep\u00falveda","year":"2017","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.spen.2017.12.002_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12888-017-1238-x","article-title":"Low intensity interventions for obsessive-compulsive disorder (OCD): a qualitative study of mental health practitioner experiences","volume":"17","author":"Gellatly","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib51","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00127-006-0118-3","article-title":"Obsessive-compulsive disorder and personality disorder","volume":"41","author":"Torres","year":"2006","journal-title":"Soc Psych Epid"},{"key":"10.1016\/j.spen.2017.12.002_bib52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archpsyc.1990.01810170087013","article-title":"Uncommon troubles in young people: prevalence estimates of selected psychiatric disorders in a nonreferred adolescent population","volume":"47","author":"Whitaker","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/08039480802315673","article-title":"Issues in the dissemination of cognitive-behavior therapy","volume":"62","author":"Taylor","year":"2008","journal-title":"Nordic J Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2105\/AJPH.92.1.92","article-title":"Adequacy of treatment for serious mental illness in the United States","volume":"92","author":"Wang","year":"2002","journal-title":"Am J Public Health"},{"key":"10.1016\/j.spen.2017.12.002_bib55","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00004583-200102000-00017","article-title":"Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial","volume":"40","author":"Riddle","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib56","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.280.20.1752","article-title":"Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial","volume":"280","author":"March","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.spen.2017.12.002_bib57","unstructured":"Centers for Disease Control. \u201cTourette Syndrome- Treatments\u201d. Available at: https:\/\/www.cdc.gov\/ncbddd\/tourette\/treatments.html."},{"key":"10.1016\/j.spen.2017.12.002_bib58","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.2200","article-title":"Obsessive-compulsive disorder: advances in diagnosis and treatment","volume":"17","author":"Hirschtritt","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.spen.2017.12.002_bib59","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/npp.2011.250","article-title":"Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial","volume":"37","author":"Hoexter","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.spen.2017.12.002_bib60","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib61","series-title":"Guideline Watch (March 2013): practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder","author":"Koran","year":"2013"},{"key":"10.1016\/j.spen.2017.12.002_bib62","first-page":"53","article-title":"American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder","volume":"164","author":"Koran","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib63","first-page":"CD001765","article-title":"Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)","volume":"1","author":"Soomro","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.spen.2017.12.002_bib64","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/01.chi.0000138356.29099.f1","article-title":"Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial","volume":"43","author":"Geller","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib65","unstructured":"Centers for Medicare and Medicaid Services (CMS.gov). \u201cProgram Integrity: Antidepressant Education Materials.\u201d Available at: https:\/\/www.cms.gov\/Medicare-Medicaid-Coordination\/Fraud-Prevention\/Medicaid-Integrity-Education\/Pharmacy-Education-Materials\/antidepressant-education.html."},{"key":"10.1016\/j.spen.2017.12.002_bib66","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaac.2016.07.768","article-title":"Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors and clomipramine in pediatric obsessive-compulsive disorder","volume":"55","author":"Varigonda","year":"2016","journal-title":"J Am Acad Child Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib67","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1176\/appi.ajp.160.11.1919","article-title":"Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder","volume":"160","author":"Geller","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.janxdis.2013.10.007","article-title":"Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis","volume":"28","author":"Sanchez-Meca","year":"2014","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.spen.2017.12.002_bib69","unstructured":"FDA.gov. Anafranil\u00ae (clomipramine) Prescribing information. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/019906s039lbl.pdf."},{"key":"10.1016\/j.spen.2017.12.002_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004583-199201000-00008","article-title":"Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder\u2014a multicenter trial","volume":"31","author":"DeVeaugh-Geiss","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib71","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12888-014-0317-5","article-title":"Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis","volume":"14","author":"Veale","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib72","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamapsychiatry.2013.1932","article-title":"Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial","volume":"70","author":"Simpson","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib73","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1037\/ccp0000025","article-title":"Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?","volume":"83","author":"Wheaton","year":"2015","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.spen.2017.12.002_bib74","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.2010.607","article-title":"Behavioral treatments for tic suppression: habit reversal training","volume":"303","author":"Piacentini","year":"2010","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.spen.2017.12.002_bib75","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cpr.2011.03.013","article-title":"The efficacy of habit reversal therapy for tics, habit disorder, and stuttering: a meta-analytic review","volume":"31","author":"Bate","year":"2011","journal-title":"Clin Psychology Rev"},{"key":"10.1016\/j.spen.2017.12.002_bib76","first-page":"7","article-title":"The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review","volume":"28","author":"Dutta","year":"2013","journal-title":"Funct Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib77","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11940-013-0238-5","article-title":"Behavior therapy for Tourette syndrome: A systematic review and meta-analysis","volume":"15","author":"Wile","year":"2013","journal-title":"Curr Treat Treat Opt Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib78","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jpsychires.2013.12.009","article-title":"A meta-analysis of behavior therapy for Tourette Syndrome","volume":"50","author":"McGuire","year":"2014","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.spen.2017.12.002_bib79","series-title":"Managing Tourette syndrome: a behavioral intervention for children and adults","author":"Woods","year":"2008"},{"key":"10.1016\/j.spen.2017.12.002_bib80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00787-011-0167-3","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioral and psychosocial interventions","volume":"20","author":"Verdellen","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib81","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archgenpsychiatry.2011.1528","article-title":"Randomized trial of behavior therapy for adults with Tourette syndrome","volume":"69","author":"Wilhelm","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib82","unstructured":"Tourette.gov CBIT training information available at www.tourette.org\/research-medical\/cbit-for-practitioners."},{"key":"10.1016\/j.spen.2017.12.002_bib83","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1901\/jaba.1998.31-447","article-title":"Applying behavior analysis to clinical problems: review and analysis of habit reversal","volume":"31","author":"Miltenberger","year":"1998","journal-title":"J Appl Behav Anal"},{"key":"10.1016\/j.spen.2017.12.002_bib84","first-page":"227","article-title":"Behavioral treatments for tic suppression: habit reversal training","volume":"99","author":"Piacentini","year":"2006","journal-title":"Adv Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib85","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neubiorev.2015.12.013","article-title":"Interventions for tic disorders: an overview of systematic reviews and meta-analyses","volume":"63","author":"Yang","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.spen.2017.12.002_bib86","series-title":"Diagnostic and statistical manual of mental disorder","first-page":"77","article-title":"Stereotypic movement disorders","year":"2013"},{"key":"10.1016\/j.spen.2017.12.002_bib87","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1469-8749.2010.03627.x","article-title":"Stereotypic movement disorder: Easily missed","volume":"52","author":"Freeman","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib88","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.spen.2009.03.008","article-title":"Motor stereotypies","volume":"16","author":"Singer","year":"2009","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib89","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1469-8749.2008.03178.x","article-title":"Motor stereotypies in children with autism and other developmental disorders","volume":"51","author":"Goldman","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib90","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.rasd.2011.07.003","article-title":"Assessment and treatment of stereotypic behavior in children with autism and other developmental disabilities: A thirty year review","volume":"6","author":"Reed","year":"2012","journal-title":"Res Autism Spectr Disord"},{"key":"10.1016\/j.spen.2017.12.002_bib91","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1474-4422(16)00132-0","article-title":"Advances in management of movement disorders in children","volume":"15","author":"Koy","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib92","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ridd.2004.11.005","article-title":"Stereotypy I: A review of behavioral assessment and treatment","volume":"26","author":"Rapp","year":"2005","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.spen.2017.12.002_bib93","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1099-078X(200004\/06)15:2<121::AID-BIN49>3.0.CO;2-O","article-title":"Functional analysis of hair manipulation: A replication and extension","volume":"15","author":"Rapp","year":"2000","journal-title":"Behav Interv"},{"key":"10.1016\/j.spen.2017.12.002_bib94","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/bin.110","article-title":"The efficacy of noncontingent reinforcement as treatment for automatically reinforced stereotypy","volume":"17","author":"Britton","year":"2002","journal-title":"Behav Interv"},{"key":"10.1016\/j.spen.2017.12.002_bib95","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1901\/jaba.2000.33-13","article-title":"An evaluation of the effects of matched stimuli on behaviors maintained by automatic reinforcement","volume":"33","author":"Piazza","year":"2000","journal-title":"J Appl Behav Anal"},{"key":"10.1016\/j.spen.2017.12.002_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1901\/jaba.2011.44-95","article-title":"Further evaluation of response interruption and redirection as treatment for stereotypy","volume":"44","author":"Ahrens","year":"2011","journal-title":"J Appl Behav Anal"},{"key":"10.1016\/j.spen.2017.12.002_bib97","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ridd.2008.02.002","article-title":"An overview of behavioral strategies for reducing hand-related stereotypies of persons with severe to profound intellectual and multiple disabilities: 1995-2007","volume":"30","author":"Lancioni","year":"2009","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.spen.2017.12.002_bib98","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/08830738060210020701","article-title":"Behavioral therapy for treatment of stereotypic movements in nonautistic children","volume":"21","author":"Miller","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib99","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/dmcn.13164","article-title":"Efficacy of parent-delivered behavioral therapy for primary complex motor stereotypies","volume":"59","author":"Spect","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/0145445507304581","article-title":"A review of behavioral treatments for self-injurious behaviors of persons with autism spectrum disorders","volume":"32","author":"Matson","year":"2008","journal-title":"Behav Modif"},{"key":"10.1016\/j.spen.2017.12.002_bib101","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2788.2007.01027.x","article-title":"Early intervention and prevention of self-injurious behavior exhibited by young children with developmental disabilities","volume":"52","author":"Richman","year":"2008","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.spen.2017.12.002_bib102","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2009.12.004","article-title":"The prevalence of neuropsychiatric disorders in Sydenham\u2032s chorea","volume":"42","author":"Ridel","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib103","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1176\/appi.ajp.157.12.2036","article-title":"The psychiatric symptoms of rheumatic fever","volume":"157","author":"Mercadante","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib104","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.genhosppsych.2008.11.003","article-title":"Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever","volume":"31","author":"Alvarenga","year":"2009","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib105","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/1531-8249(200003)47:3<404::AID-ANA23>3.0.CO;2-X","article-title":"William Osler: on chorea: on Charcot","volume":"47","author":"Goetz","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib106","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/0883073814544704","article-title":"Sydenham chorea and PANDAS in South Africa: review of evidence and recommendations for management in resource-poor countries","volume":"30","author":"Walker","year":"2015","journal-title":"J Child Neur"},{"key":"10.1016\/j.spen.2017.12.002_bib107","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.parkreldis.2005.11.003","article-title":"Sydenham\u2032s chorea is associated with decreased verbal fluency","volume":"12","author":"Cunningham","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.spen.2017.12.002_bib108","series-title":"Inflammatory and autoimmune disorders of the nervous system in children","first-page":"120","article-title":"Sydenham chorea","author":"Cardoso","year":"2010"},{"key":"10.1016\/j.spen.2017.12.002_bib109","series-title":"Epilepsy and Movement Disorders","first-page":"359","article-title":"Sydenham chorea","author":"Garvey","year":"2002"},{"key":"10.1016\/j.spen.2017.12.002_bib110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/adc.2003.031856","article-title":"Dyskinesias and associated psychiatric disorders following streptococcal infection","volume":"89","author":"Dale","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.spen.2017.12.002_bib111","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/cap.2010.0043","article-title":"The immunobiology of Tourette\u2032s disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward","volume":"20","author":"Murphy","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.spen.2017.12.002_bib112","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1542\/peds.113.4.907","article-title":"The pediatric autoimmune neuropsychiatric disorders associated with streptoccocal infection (PANDAS) subgroup: separating fact from fiction","volume":"113","author":"Swedo","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.12.002_bib113","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archpsyc.57.4.364","article-title":"Preliminary findings of antistreptocccal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit\/hyperactivity disorders","volume":"57","author":"Peterson","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib114","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1056-4993(18)30152-4","article-title":"Immune mechanisms in pediatric neuropsychiatric disorders: Tourette\u2032s syndrome, OCD, and PANDAS","volume":"8","author":"Trifiletti","year":"1999","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.spen.2017.12.002_bib115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5694\/j.1326-5377.2007.tb01059.x","article-title":"Rheumatic Fever Guidelines Writing Group. An Australian guideline for rheumatic fever and rheumatic heart disease: An abridged outline","volume":"186","author":"Carapetis","year":"2007","journal-title":"Med J Aust"},{"key":"10.1016\/j.spen.2017.12.002_bib116","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/bmj.39031.420637.BE","article-title":"Rheumatic fever and its management","volume":"333","author":"Cilliers","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.spen.2017.12.002_bib117","series-title":"Red Book: 2012 Report of the Committee on Infectious Diseases","first-page":"678","article-title":"Group A Streptococcal Infections","year":"2012"},{"key":"10.1016\/j.spen.2017.12.002_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2009.11.015","article-title":"Sydenham\u2032s Chorea: A practical overview of the current literature","volume":"43","author":"Oosterveer","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib119","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.spen.2017.12.002_bib120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/dmcn.13349","article-title":"Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders","volume":"59","author":"Gadian","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib121","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11011-015-9681-1","article-title":"Neuropsychological manifestations in children with Sydenham\u2032s chorea after adjunct intravenous immunoglobulin and standard treatment","volume":"31","author":"Gregorowski","year":"2016","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.spen.2017.12.002_bib122","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood","volume":"354","author":"Perlmutter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2017.12.002_bib123","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(99)00204-4","article-title":"PANDAS and immunomodulatory therapy","volume":"354","author":"Singer","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2017.12.002_bib124","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jaac.2016.06.017","article-title":"Randomized, controlled trial of intravenous immunoglobulin for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"55","author":"Williams","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mrdd.1022","article-title":"Juvenile onset Huntington\u2032s disease: Clinical and research perspectives","volume":"7","author":"Nance","year":"2001","journal-title":"Mental Retardation Dev Disabilities Res Reviews"},{"key":"10.1016\/j.spen.2017.12.002_bib126","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archneur.64.6.813","article-title":"Psychiatric and cognitive difficulties as indicators of juvenile Huntington disease onset in 29 patients","volume":"64","author":"Ribai","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib127","first-page":"223","article-title":"Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature","volume":"21","author":"Gonzalez-Alegre","year":"2006","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib128","first-page":"913","article-title":"Huntington\u2032s disease in children","volume":"Vol. 113","author":"Letort","year":"2013"},{"key":"10.1016\/j.spen.2017.12.002_bib129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/YIC.0b013e3283407775","article-title":"Risperidone long-acting injection and Huntington\u2032s disease: case series with significant psychiatric and behavioral symptoms","volume":"26","author":"Johnston","year":"2011","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.spen.2017.12.002_bib130","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/01.chi.0000134494.65678.65","article-title":"Huntington disease: a case study of early onset presenting as depression","volume":"43","author":"Duesterhus","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib131","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/chi.0b013e31802ed8c9","article-title":"Huntington\u2032s disease presenting as a depressive disorder with psychotic features (letter to the editor)","volume":"46","author":"Jardri","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.spen.2017.12.002_bib132","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-0004.2006.00702.x","article-title":"Young people\u2032s experiences of growing up in a family affected by Huntington\u2032s disease","volume":"71","author":"Keenan","year":"2007","journal-title":"Clin Genet"},{"key":"10.1016\/j.spen.2017.12.002_bib133","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10897-008-9151-6","article-title":"Experiences of teens living in the shadow of Huntington disease","volume":"17","author":"Sparbel","year":"2008","journal-title":"J Genet Counsel"},{"key":"10.1016\/j.spen.2017.12.002_bib134","unstructured":"Austedo (deutetrabenazine) [package insert] Peta Tikva, Israel: Teva, 2017."},{"key":"10.1016\/j.spen.2017.12.002_bib135","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1177\/0883073808314152","article-title":"Juvenile Huntington disease exacerbated by methylphenidate: case report","volume":"23","author":"Waugh","year":"2008","journal-title":"J. Child Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib136","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1469-8749.2011.03955.x","article-title":"Childhood disorders of neurodegeneration with brain iron accumulation (NBIA)","volume":"53","author":"Kurian","year":"2011","journal-title":"Dev Med & Child Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib137","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng572","article-title":"A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome","volume":"28","author":"Zhou","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2017.12.002_bib138","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mds.10650","article-title":"Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallevorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration","volume":"19","author":"Thomas","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2017.12.002_bib139","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1212\/01.WNL.0000161843.52641.EC","article-title":"The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration","volume":"64","author":"Pellecchia","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.12.002_bib140","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00008480-200312000-00005","article-title":"Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name","volume":"15","author":"Hayflick","year":"2003","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.spen.2017.12.002_bib141","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clineuro.2017.01.011","article-title":"Clinical and genetic features of PKAN patients in a tertiary centre in Turkey","volume":"154","author":"Akcakaya","year":"2017","journal-title":"Clin Neurol Neurosurgery"},{"key":"10.1016\/j.spen.2017.12.002_bib142","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00415-010-5688-z","article-title":"Conversion disorder as initial diagnosis in pantothenate kinase-associated neurodegeneration","volume":"258","author":"Vansteenkiste","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.spen.2017.12.002_bib143","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1176\/appi.neuropsych.11090228","article-title":"Pantothenate kinase-associated neurodegeneration (PKAN) presenting with language deterioration, personality alteration, and severe parkinsonism","volume":"24","author":"Sakarya","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.spen.2017.12.002_bib144","series-title":"Diagnostic and statistical manual of mental disorders","first-page":"195","article-title":"Selective mutism","year":"2013"},{"key":"10.1016\/j.spen.2017.12.002_bib145","series-title":"Treating Tourette syndrome and tic disorders","first-page":"22","article-title":"Assessment of tic disorders","author":"Woods","year":"2007"},{"key":"10.1016\/j.spen.2017.12.002_bib146","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1034\/j.1600-0447.2003.00159.x","article-title":"Psychotic disorder in a case with Hallervorden-Spatz disease","volume":"108","author":"Oner","year":"2003","journal-title":"Acta Psychiatr Scan"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117301511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117301511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T10:05:10Z","timestamp":1570529110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909117301511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":146,"alternative-id":["S1071909117301511"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2017.12.002","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychiatric Treatment and Management of Psychiatric Comorbidities of Movement Disorders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}